Showing results (5331-5340 of 5,723) with videos related to

Sort By:
Pageof 573
BMC Nephrology|September 14, 2018
Physical activity promotion for patients transitioning to dialysis using the "Exercise is Medicine" framework: a multi-center randomized pragmatic trial (EIM-CKD trial) protocolRam Jagannathan, Susan Lynn Ziolkowski, Mary Beth Weber, et al.
BMC Nephrology|April 15, 2018
Serum BTP concentrations are not affected by hepatic dysfunctionDebarati Chakraborty, Ayub Akbari, Greg A Knoll, et al.
BMC Nephrology|April 13, 2019
miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinomaCheng He, Zhi-Yong Chen, Yang Li, et al.
BMC Nephrology|April 18, 2019
Association between prediabetes (defined by HbA1C, fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: a 9-year prospective cohort studyGwang Sil Kim, Hyun Ho Oh, Sang Hyun Kim, et al.
BMC Nephrology|August 18, 2018
Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patientsChaomin Zhou, Hongying Peng, Jing Yuan, et al.
BMC Nephrology|August 18, 2018
Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort studyWouter R Verberne, Janneke Dijkers, Johannes C Kelder, et al.
BMC Nephrology|August 19, 2018
Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Schönlein purpura nephritis: a multicenter retrospective cohort studyKoji Inagaki, Ahmad Baseer Kaihan, Asaka Hachiya, et al.
BMC Nephrology|August 24, 2018
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalinkHans Furuland, Phil McEwan, Marc Evans, et al.
BMC Nephrology|June 13, 2019
Factors influencing survival time of hemodialysis patients; time to event analysis using parametric models: a cohort studyVahid Ebrahimi, Mohammad Hossein Khademian, Seyed Jalil Masoumi, et al.
BMC Nephrology|June 16, 2019
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejectionKasia A Sablik, Marian C Clahsen-van Groningen, Caspar W N Looman, et al.
Pageof 573